Skip to main content

Angelman Syndrome

  • Chapter

Abstract

Angelman syndrome (AS) is a rare neurogenetic and neurodevelopmental condition that was first described by the English pediatrician, Harry Angelman MD (1915–1996). Diagnostic criteria notes that those with AS have severe developmental delay, significant speech dysfunction, impaired balance or movement, and features of an apparent happy countenance. There is mutation or abnormal expression in the ubiquitin ligase gene, UBE3A, found at 15q11.2. Comprehensive management includes careful attention to developmental delay and seizure control. As the science of gene therapy improves, more specific treatment of Angelman syndrome is expected as the twenty-first century continues and hopefully will answer the optimism portrayed in the emoticon of persons with Angelman syndrome.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   389.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   499.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Angelman H. “Puppet” children: a report of three cases. Dev Med Child Neurol. 1965;7(6):681–8.

    Article  Google Scholar 

  2. Guerrini R, Carrozzo R, Rinaldi R, Bonanni P. Angelman syndrome: etiology, clinical features, diagnosis, and management of symptoms. Paedaitric Drugs. 2003;5(10):647–61.

    Article  Google Scholar 

  3. Williams CA, Angelman H, Clayton-Smith J, Driscoll DJ, Hendrickson JE, Knoll JHM, et al. Angelman syndrome: consensus for diagnostic criteria. Am J Med Genet. 1995;56:237–8.

    Article  CAS  PubMed  Google Scholar 

  4. Williams CA. The behavioral phenotype of the Angleman syndrome. Am J Med Genet C Semin Med Genet. 2010;154C(4):432–7.

    Article  PubMed  Google Scholar 

  5. Wagstaff J. Angelman syndrome. In: Ruybin IL, Crocker AC, editors. Medical care for children and adults with developmental disabilities. 2nd ed. Baltimore: Paul Brookes; 2006. p. 200–6.

    Google Scholar 

  6. Clayton-Smith J, Laan L. Angelman syndrome: a review of the clinical and genetic aspects. J Med Genet. 2003;40(2):87–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Hall BD, Toriello HV. The pediatric dysmorphology diagnostic examination. In: Greydanus DE, Feinberg AN, Patel DR, Hominick DN, editors. The pediatric diagnostic examination. New York: McGraw-Hill Medical; 2008. p. 136.

    Google Scholar 

  8. Dan B. Angelman syndrome: current understanding and research prospects. Epilepsia. 2009;50(11):2331–9.

    Article  PubMed  Google Scholar 

  9. Horváth E, Horváth Z, Isaszegi D, Gergev G, Nagy N, Szabó J, et al. Early detection of Angelman syndrome resulting from de novo paternal isodisomic 15q UPD and review of compatible cases. Mol Cytogenet. 2013;6(1):35–8.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Dagli A, Buiting K, Williams CA. Molecular and clinical aspects of Angelman syndrome. Mol Syndromol. 2012;2(3–5):100–12.

    CAS  PubMed  Google Scholar 

  11. Williams CA, Driscoll DJ, Dagli AI. Clinical and genetic aspects of Angelman syndrome. Genet Med. 2010;12(7):385–95.

    Article  CAS  PubMed  Google Scholar 

  12. Clarke DJ, Marston G. Problem behaviors association with the 15q- Angelman syndrome. Am J Ment Retard. 2000;105(1):25–31.

    Article  CAS  PubMed  Google Scholar 

  13. Fiumara A, Pittalà A, Cocuzza M, Sorge G. Epilepsy in patients with Angelman syndrome. Ital J Pediatr. 2010;36:31–5.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Laan LAEM, Vein AA. Angelman syndrome: is there a characteristic EEG? Brain Dev. 2005;27:80–7.

    Article  PubMed  Google Scholar 

  15. Williams CA. Neurological aspects of the Angelman syndrome. Brain Dev. 2005;27(2):88–94.

    Article  PubMed  Google Scholar 

  16. Bjerre I, Fagher B, Ryding E, Rosén I. The Angelman or “happy puppet” syndrome. Clinical and electroencephalographic features and cerebral blood flow. Acta Paediatr Scand. 1984;73(3):398–402.

    Article  CAS  PubMed  Google Scholar 

  17. Anderson WH, Rasmussen RK, Strømme P. Levels of cognition and linguistic development in Angelman syndrome: a study of 20 children. Logopedics Phoniatr Vocology. 2001;26(1):2–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Donald E. Greydanus M.D., DrHC (Athens) .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Greydanus, D.E., Pratt, H.D., Pryson, M. (2016). Angelman Syndrome. In: Rubin, I.L., Merrick, J., Greydanus, D.E., Patel, D.R. (eds) Health Care for People with Intellectual and Developmental Disabilities across the Lifespan. Springer, Cham. https://doi.org/10.1007/978-3-319-18096-0_68

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-18096-0_68

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-18095-3

  • Online ISBN: 978-3-319-18096-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics